Literature DB >> 8420762

Infectious complications of endoscopic procedures in bone marrow transplant recipients.

M Kaw1, D Przepiorka, G Sekas.   

Abstract

The prevalence of clinically relevant bacteremia after endoscopic procedures in bone marrow transplant recipients was assessed retrospectively. Bacteremia, within 24 hr of procedure, was defined as positive blood cultures, while hypotension and temperature greater than 38 degrees C were taken as possible indicators of bacteremia. Sixty-seven procedures were performed in 53 endoscopic sessions (upper endoscopy 37, flexible sigmoidoscopy 7, upper endoscopy + flexible sigmoidoscopy 8, colonoscopy 1). Twenty-five endoscopic sessions were performed in patients receiving broad-spectrum antibiotics and 28 sessions in patients not receiving antibiotics. Both groups were comparable with respect to patient characteristics, procedures performed, and immune status. No patient in either group developed hypotension. One patient developed fever after flexible sigmoidoscopy; no source of fever was identified. We conclude that: (1) there were no episodes of clinically relevant bacteremia attributable to endoscopic procedures, and (2) not all bone marrow transplant recipients require routine antibiotic prophylaxis prior to endoscopic procedures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420762     DOI: 10.1007/bf01296776

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey.

Authors:  S E Silvis; O Nebel; G Rogers; C Sugawa; P Mandelstam
Journal:  JAMA       Date:  1976-03-01       Impact factor: 56.272

Review 2.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

Review 3.  Reconstruction of the haemopoietic and immune systems after marrow transplantation.

Authors:  K Atkinson
Journal:  Bone Marrow Transplant       Date:  1990-04       Impact factor: 5.483

4.  Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock.

Authors:  O Idsoe; T Guthe; R R Willcox; A L de Weck
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

Review 5.  Infections in bone marrow transplant recipients.

Authors:  D Engelhard; M I Marks; R A Good
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

Review 6.  Immunosuppression for clinical marrow transplantation.

Authors:  G W Santos
Journal:  Semin Hematol       Date:  1974-07       Impact factor: 3.851

7.  Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients.

Authors:  J A Bianco; M S Pepe; C Higano; F R Applebaum; G B McDonald; J W Singer
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

Review 8.  Advances in the management of infectious complications after bone marrow transplantation.

Authors:  J R Wingard
Journal:  Bone Marrow Transplant       Date:  1990-12       Impact factor: 5.483

9.  Neutrophil function and pyogenic infections in bone marrow transplant recipients.

Authors:  W Zimmerli; A Zarth; A Gratwohl; B Speck
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

Review 10.  Bacteremia with gastrointestinal endoscopic procedures.

Authors:  V A Botoman; C M Surawicz
Journal:  Gastrointest Endosc       Date:  1986-10       Impact factor: 9.427

View more
  2 in total

Review 1.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 2.  Endoscopy in neutropenic and/or thrombocytopenic patients.

Authors:  Michelle C Tong; Micheal Tadros; Haleh Vaziri
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.